Health and Healthcare

Eli Lilly : LLY

All Eli Lilly Articles

649 Articles

Chris Lange | May 19, 2016 at 10:20 AM EDT

8 Stocks on the Move After ASCO Cancer Abstracts

ASCO has just released the abstracts for its exhibitors ahead of the conference. For investors and analysts, sometimes winners or…

Lee Jackson | May 11, 2016 at 9:45 AM EDT

3 Safe Blue Chip Stocks to Buy as Markets Could Be in Trouble

With a flight to cash hardly workable for most investors, and Treasury bonds seemingly very rich, quality low-volatility dividend stocks…

Jon C. Ogg | May 10, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Bats, Eli Lilly, Gap, Hasbro, JD.com, Nike, Pfizer, SolarCity and More

The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Bats Global Markets, Eli Lilly, Gap, Hasbro, JD.com,…

Chris Lange | Apr 25, 2016 at 12:15 PM EDT

What to Expect When Eli Lilly Reports Earnings

Eli Lilly is set to release its first-quarter earnings report before the markets open on Tuesday.

Lee Jackson | Mar 30, 2016 at 11:05 AM EDT

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

Long-term growth investors looking for a degree of safety and value should consider some of these outstanding companies. While the…

Chris Lange | Mar 28, 2016 at 9:10 AM EDT

5 Credit Suisse Focus List Stocks With the Most Upside

In a new research report, Credit Suisse highlighted some companies on its U.S. Focus List that stand to have the…

Lee Jackson | Mar 23, 2016 at 10:05 AM EDT

As Institutional Investors Continue to Sell, 4 Safe Dividend Stocks to Buy and Hold

These four solid companies to buy and hold all can do well, and even if the market sells off, the…

Jon C. Ogg | Mar 23, 2016 at 8:45 AM EDT

The Next Mega-Caps: 7 Stocks Likely to Be Worth $100 Billion Soon

24/7 Wall St. has identified seven companies that could easily reach the $100 billion mark to become the next mega-cap…

Paul Ausick | Mar 17, 2016 at 4:04 PM EDT

The 52-Week Low Club for Thursday

March 17, 2016: Here are four stocks trading with heavy volume among 60 equities making new 52-week lows in Thursday’s…

Paul Ausick | Mar 15, 2016 at 4:04 PM EDT

The 52-Week Low Club for Tuesday

March 15, 2016: Here are four stocks trading with heavy volume among 33 equities making new 52-week lows in Tuesday’s…

Chris Lange | Mar 15, 2016 at 9:25 AM EDT

Jefferies Top Drug Stocks for the Rest of 2016

For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made…

Lee Jackson | Feb 29, 2016 at 10:45 AM EST

Deutsche Bank Sees 4 Big Pharmaceutical Stocks as Cheap With Solid Dividends

With investors looking for safety and dividends for total return, the big pharmaceutical stocks are just the ticket, and these…

Lee Jackson | Feb 22, 2016 at 11:40 AM EST

Big Dividend Pharmaceutical Stock Now Jefferies Top Global Sector Pick

In a new research report, Jefferies shuffles some of the pharmaceutical stocks in its coverage universe and a beaten-down dividend…

Lee Jackson | Feb 8, 2016 at 8:25 AM EST

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

If you ever want to look for value in a sector in the stock market, then when you see Congress…

Lee Jackson | Feb 2, 2016 at 9:50 AM EST

Wall Street Is as Bearish as 2009: 4 Top Dividend Stocks to Buy Right Now

24/7 Wall St. screened the Merrill Lynch research universe database and found four outstanding dividend stocks that are rated Buy…

1 … 28 29 30 31 32 … 44

Eli Lilly : LLY

All Eli Lilly Articles

8 Stocks on the Move After ASCO Cancer Abstracts

3 Safe Blue Chip Stocks to Buy as Markets Could Be in Trouble

Top Analyst Upgrades and Downgrades: Bats, Eli Lilly, Gap, Hasbro, JD.com, Nike, Pfizer, SolarCity and More

What to Expect When Eli Lilly Reports Earnings

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

5 Credit Suisse Focus List Stocks With the Most Upside

As Institutional Investors Continue to Sell, 4 Safe Dividend Stocks to Buy and Hold

The Next Mega-Caps: 7 Stocks Likely to Be Worth $100 Billion Soon

The 52-Week Low Club for Thursday

The 52-Week Low Club for Tuesday

Jefferies Top Drug Stocks for the Rest of 2016

Deutsche Bank Sees 4 Big Pharmaceutical Stocks as Cheap With Solid Dividends

Big Dividend Pharmaceutical Stock Now Jefferies Top Global Sector Pick

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

Wall Street Is as Bearish as 2009: 4 Top Dividend Stocks to Buy Right Now

The After-Tax 401(k) Move That Lets High Earners Shelter $36,250 More in a Roth Every Year in 2026

‘Chances Are He Will’: Suze Orman Warns a Worried Mom That Her Will Won’t Protect Her Daughters

Her Husband Died at 48. His Survivor Benefit Pays $2,300 a Month, More Than the Check She Earned Herself.

The After-Tax 401(k) Move That Lets High Earners Shelter $36,250 More in a Roth Every Year in 2026

'Chances Are He Will': Suze Orman Warns a Worried Mom That Her Will Won't Protect Her Daughters

The After-Tax 401(k) Move That Lets High Earners Shelter $36,250 More in a Roth Every Year in 2026

‘Chances Are He Will’: Suze Orman Warns a Worried Mom That Her Will Won’t Protect Her Daughters

Eli Lilly : LLY

All Eli Lilly Articles

8 Stocks on the Move After ASCO Cancer Abstracts

3 Safe Blue Chip Stocks to Buy as Markets Could Be in Trouble

Top Analyst Upgrades and Downgrades: Bats, Eli Lilly, Gap, Hasbro, JD.com, Nike, Pfizer, SolarCity and More

What to Expect When Eli Lilly Reports Earnings

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

5 Credit Suisse Focus List Stocks With the Most Upside

As Institutional Investors Continue to Sell, 4 Safe Dividend Stocks to Buy and Hold

The Next Mega-Caps: 7 Stocks Likely to Be Worth $100 Billion Soon

The 52-Week Low Club for Thursday

The 52-Week Low Club for Tuesday

Jefferies Top Drug Stocks for the Rest of 2016

Deutsche Bank Sees 4 Big Pharmaceutical Stocks as Cheap With Solid Dividends

Big Dividend Pharmaceutical Stock Now Jefferies Top Global Sector Pick

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

Wall Street Is as Bearish as 2009: 4 Top Dividend Stocks to Buy Right Now

The After-Tax 401(k) Move That Lets High Earners Shelter $36,250 More in a Roth Every Year in 2026

‘Chances Are He Will’: Suze Orman Warns a Worried Mom That Her Will Won’t Protect Her Daughters

Her Husband Died at 48. His Survivor Benefit Pays $2,300 a Month, More Than the Check She Earned Herself.

Featured Reads

The After-Tax 401(k) Move That Lets High Earners Shelter $36,250 More in a Roth Every Year in 2026

'Chances Are He Will': Suze Orman Warns a Worried Mom That Her Will Won't Protect Her Daughters